Video
Dr. Elterman weighs in on the growing number of BPH treatments available
Author(s):
“My patient selection process for BPH treatments can be a little bit cumbersome and take time, but that's really because for the first time ever, we have so many different options available to men,” says Dean Elterman, MD, MSc, FRCSC.
Video Player is loading.
In this video, Dean Elterman, MD, MSc, FRCSC, discusses the patient selection process and methods he uses to conduct BPH treatment studies, specifically implementing Rezum and Aquablation therapies. Elterman is an associate professor of urology at University of Toronto and an attending urologist at the University Health Network, Toronto, Canada.
Related Videos
John Michael DiBianco, MD, on silicone vs polyurethane stents for patients with kidney stones
Félix Guerrero-Ramos, MD, on TAR-200 in papillary disease-only NMIBC
BPH Treatment and Impact on Sexual Health
Khurshid Ghani, MD, on trial of stent omission following ureteroscopy
Karyn S. Eilber, MD, shares her reaction to genitourinary syndrome of menopause guidelines
Expert discusses the relationship between RCTs and real-world efficacy of prostate cancer treatments
Endourologist discusses shared decision-making and laser lithotripsy
Shreyas Joshi, MD, recaps AUA session on chemotherapy vs novel NMIBC options
Joshua J. Meeks, MD, PhD, discusses NIAGARA data for patient undergoing cystectomy
Shay Rajavel, MS3, on CO2 gas embolism during single-port partial nephrectomy
Related Content
